Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Biogen 2010 third quarter revenue increase 5% to $1.2 billion

Biogen Idec Inc. a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its third quarter 2010 results.

26 Oct 2010

Synergetics announces record sales leads generated from ophthalmic products

Synergetics USA, Inc. a medical device company that designs, manufactures, and markets innovative devices for ophthalmic and neurosurgical applications, today announced record sales leads generated from the presentation of recently released ophthalmic products at the 2010 Annual Meeting of the American Academy of Ophthalmology (AAO). The AAO meeting was held in Chicago's McCormick Place on October 16-19, 2010.

26 Oct 2010

PharmaVentures acts as advisor and broker to Dr Reddy's in distribution agreement with Vitabiotics

PharmaVentures Ltd announced today that it had acted as the advisor and broker to the Indian pharmaceutical company Dr Reddy's Laboratories in its successful marketing and distribution agreement with the UK healthcare company Vitabiotics Ltd for a range of nutraceutical products. The agreement provides Dr Reddy's exclusive marketing rights in the Russian/CIS markets for two of Vitabiotics' leading products - Jointace and Dietrim. Vitabiotics will supply these products on a long-term basis from its facilities in Europe.

From Vitabiotics Ltd. 26 Oct 2010

Contraband tobacco accounts for 43% of cigarettes consumed by Ontario students

A new study from The Centre for Addiction and Mental Health (CAMH) found that contraband tobacco accounts for 43% of all cigarettes consumed by Ontario high school daily smokers in grades 9 to 12.

26 Oct 2010

IDC grants MedImmune global rights to GLA adjuvant

Immune Design Corp. (IDC), a privately held biotechnology company developing novel vaccines and immunotherapies for infectious disease and cancer, announced today that it has entered into a license and development agreement with MedImmune for the use and commercialization of IDC’s proprietary Glucopyranosyl Lipid Adjuvant (GLA) as a component in vaccines for select infectious diseases.

26 Oct 2010

AAHP highlights safety of homeopathic children's medicines

The American Association of Homeopathic Pharmacists (AAHP), representing the major manufacturers and distributors of homeopathic drugs, highlights the safety of homeopathic children's medicines in response to the recall of Hyland's Teething Tablets. The AAHP supports the efforts to protect the safety of children by both the Standard Homeopathic Company and the U.S. Food and Drug Administration (FDA).

26 Oct 2010

Mergers between hospitals and insurers expected to increase

"Health system reform, in combination with economic factors and trends in play, is expected to speed consolidation of health insurers and hospitals, leaving physicians to figure out how they should adapt," American Medical News reports. "The prospect for mergers and acquisitions throughout the industry is high thanks not only to health system reform, but also more access to financing to buy up other companies.

25 Oct 2010

ATMI and Austar open new Chinese manufacturing facility

ATMI, Inc. today announced that it has further extended its global biopharma manufacturing footprint with the opening of a new Chinese manufacturing facility as part of a joint venture with Austar, a Hong Kong-based comprehensive service provider to the China pharmaceutical industry.

25 Oct 2010

ThermalTherapeutic Systems, Applied Medical enter strategic alliance

ThermalTherapeutic Systems, Inc., the developer of a highly portable platform technology designed to standardize hyperthermic perfusion treatments, today announced a strategic alliance with Applied Medical Products and Solutions of Boston, MA.

25 Oct 2010

CryoLife commences European distribution of PerClot polysaccharide hemostatic agent

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that it has begun European distribution of PerClot®, a novel polysaccharide hemostatic agent used to control bleeding during surgical procedures or following traumatic injuries.

25 Oct 2010

NeedleTech increases production area with new 73,000-square foot manufacturing facility

U.S. Congressman James McGovern, State Representative Elizabeth Poirier and local dignitaries joined Theragenics Corporation executives in ribbon cutting ceremonies on October 15 for a new 73,000-square foot manufacturing facility for the company's subsidiary, NeedleTech Products. The new facility increases NeedleTech's production area by 30% or 20,000 square feet, allowing the company to consolidate two separate older facilities into one location. The new building will allow NeedleTech to expand operations, increase R&D and offer more services to its customers.

25 Oct 2010

Biomerix enters distribution agreement with Medline

Biomerix Corporation, a medical technology company developing and manufacturing innovative hernia repair products, today announced that it has entered into an exclusive distribution agreement with Medline Industries, Inc., the nation's largest privately held manufacturer and distributor of medical and surgical products in the United States.

25 Oct 2010

FDA warns about risk of Hyland's Teething Tablets to children

The U.S. Food and Drug Administration today is warning consumers that Hyland's Teething Tablets may pose a risk to children. The FDA recommends that consumers not use this product and dispose of any in their possession. The manufacturer is issuing a recall of this product.

25 Oct 2010

VTI expands into consumer electronics segment

VTI Technologies, a pioneer in Micro-Electro-Mechanical Systems (MEMS) for the past 20 years, is now taking a new direction and expanding into the consumer electronics segment. VTI is already the market leader in low-g sensors for the automotive industry, as well as in ultra-low power sensors for the medical implantable market.

25 Oct 2010

FDA issues complete response letter for ViroPharma's Cinryze

ViroPharma Incorporated today announced the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding Cinryze (C1 Esterase Inhibitor [Human]) industrial scale manufacturing expansion activities. The FDA has requested additional information related to observations from the pre-approval inspection and review of the technical processes.

25 Oct 2010

Research project on food allergy to showcase results at symposium in Nice

A research project on food allergy that involved 25 countries worldwide will showcase some of its results at a symposium in Nice starting today. "What we found won't make it easy to pinpoint which foods carry the biggest risk, as the risk for individual foods varies from country to country," says project coordinator Professor Clare Mills from the Institute of Food Research.

22 Oct 2010

Occlutech receives favorable appeal court ruling against patent litigation with AGA Medical

Occlutech GmbH, the leading European developer of minimally invasive implants for the treatment of structural heart disease, today announced receiving a favourable appeal court ruling from The Hague, The Netherlands in the on-going patent litigation with AGA Medical. A favourable first instance court ruling obtained by Occlutech had been appealed by AGA in 2008.

22 Oct 2010

Paragon Bioservices awarded contract to assist USAMRIID in vaccine development efforts

Paragon Bioservices, a Baltimore-based CMO focused on the contract research, process development and manufacturing of biologics, announced today that it has been awarded a $4.99 million contract to assist the U.S. Army Medical Research Institute for Infectious Diseases in its vaccine development efforts.

22 Oct 2010

New York Times Magazine examines individual-initiated foreign aid projects

A New York Times Magazine article by the newspaper's Op-Ed columnist Nicolas Kristof examines a "revolution" that is "just beginning" and "might be called Do-It-Yourself Foreign Aid, because it starts with the proposition that it's not only presidents and United Nations officials who chip away at global challenges. Passionate individuals with great ideas can do the same, especially in the age of the Internet and social media."

22 Oct 2010

Novartis releases study results on oral calcitonin for treatment of osteoarthritis: Unigene Laboratories

Unigene Laboratories, Inc. announced today that Novartis has released information on the first of two studies on oral calcitonin for the treatment of osteoarthritis conducted by its license partner Nordic Bioscience. The recently completed Study 2301, which assesses the safety and efficacy of oral calcitonin in the treatment of knee osteoarthritis, had three co-primary endpoints.

22 Oct 2010

Manufacturing News and Research

Further Reading

Biogen 2010 third quarter revenue increase 5% to $1.2 billion

Synergetics announces record sales leads generated from ophthalmic products

PharmaVentures acts as advisor and broker to Dr Reddy's in distribution agreement with Vitabiotics

Contraband tobacco accounts for 43% of cigarettes consumed by Ontario students

IDC grants MedImmune global rights to GLA adjuvant

AAHP highlights safety of homeopathic children's medicines

Mergers between hospitals and insurers expected to increase

ATMI and Austar open new Chinese manufacturing facility

ThermalTherapeutic Systems, Applied Medical enter strategic alliance

CryoLife commences European distribution of PerClot polysaccharide hemostatic agent

NeedleTech increases production area with new 73,000-square foot manufacturing facility

Biomerix enters distribution agreement with Medline

FDA warns about risk of Hyland's Teething Tablets to children

VTI expands into consumer electronics segment

FDA issues complete response letter for ViroPharma's Cinryze

Research project on food allergy to showcase results at symposium in Nice

Occlutech receives favorable appeal court ruling against patent litigation with AGA Medical

Paragon Bioservices awarded contract to assist USAMRIID in vaccine development efforts

New York Times Magazine examines individual-initiated foreign aid projects

Novartis releases study results on oral calcitonin for treatment of osteoarthritis: Unigene Laboratories

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News